Global Safety Lancets Market Growth 2026-2032
The global Safety Lancets market size is predicted to grow from US$ 668 million in 2025 to US$ 984 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.
Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor?s offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.In 2025, global Safety lancets production reached approximately 14.23 billlion units and price is about 48 USD/Unit.
Drivers of the Safety Lancets Market:
Increasing Prevalence of Diabetes: The growing incidence of diabetes globally has led to a rise in the demand for frequent blood glucose monitoring. Safety lancets are widely used in diabetes management, driving the market.
Focus on Safety and Infection Control: Concerns over needle-stick injuries and blood borne infections are pushing healthcare providers to adopt safer devices like safety lancets, which minimize these risks through single-use mechanisms.
Rising Home Healthcare Adoption: The trend toward home-based care, especially for patients with chronic conditions, has increased the demand for user-friendly medical devices, including safety lancets.
Technological Innovation: Advancements in lancet design, such as automatic, pain-minimizing, and ergonomically improved lancets, are enhancing patient experience and encouraging wider adoption.
Government Regulations and Support: Many governments have implemented strict regulations that favor the use of safety-engineered devices to improve healthcare worker safety, fostering the growth of the safety lancets market.
Challenges of the Safety Lancets Market:
Higher Costs: Safety lancets tend to be more expensive than traditional lancets, which can limit adoption, especially in low-resource healthcare settings.
Lack of Awareness in Developing Regions: Limited awareness of safety lancets, along with insufficient healthcare infrastructure in developing countries, hampers market penetration.
Environmental Impact: The single-use nature of safety lancets contributes to medical waste, raising concerns about environmental sustainability and prompting the search for more eco-friendly solutions.
Competition from Alternative Technologies: Emerging blood sampling technologies, such as continuous glucose monitoring (CGM) systems that reduce the need for finger pricking, may present competition to safety lancets.
Limited Reimbursement Policies: In some regions, the lack of favorable reimbursement policies for diagnostic devices like safety lancets can act as a barrier to widespread adoption.
LP Information, Inc. (LPI) ' newest research report, the ?Safety Lancets Industry Forecast? looks at past sales and reviews total world Safety Lancets sales in 2025, providing a comprehensive analysis by region and market sector of projected Safety Lancets sales for 2026 through 2032. With Safety Lancets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Safety Lancets industry.
This Insight Report provides a comprehensive analysis of the global Safety Lancets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Safety Lancets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Safety Lancets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Safety Lancets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Safety Lancets.
This report presents a comprehensive overview, market shares, and growth opportunities of Safety Lancets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor?s offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.In 2025, global Safety lancets production reached approximately 14.23 billlion units and price is about 48 USD/Unit.
Drivers of the Safety Lancets Market:
Increasing Prevalence of Diabetes: The growing incidence of diabetes globally has led to a rise in the demand for frequent blood glucose monitoring. Safety lancets are widely used in diabetes management, driving the market.
Focus on Safety and Infection Control: Concerns over needle-stick injuries and blood borne infections are pushing healthcare providers to adopt safer devices like safety lancets, which minimize these risks through single-use mechanisms.
Rising Home Healthcare Adoption: The trend toward home-based care, especially for patients with chronic conditions, has increased the demand for user-friendly medical devices, including safety lancets.
Technological Innovation: Advancements in lancet design, such as automatic, pain-minimizing, and ergonomically improved lancets, are enhancing patient experience and encouraging wider adoption.
Government Regulations and Support: Many governments have implemented strict regulations that favor the use of safety-engineered devices to improve healthcare worker safety, fostering the growth of the safety lancets market.
Challenges of the Safety Lancets Market:
Higher Costs: Safety lancets tend to be more expensive than traditional lancets, which can limit adoption, especially in low-resource healthcare settings.
Lack of Awareness in Developing Regions: Limited awareness of safety lancets, along with insufficient healthcare infrastructure in developing countries, hampers market penetration.
Environmental Impact: The single-use nature of safety lancets contributes to medical waste, raising concerns about environmental sustainability and prompting the search for more eco-friendly solutions.
Competition from Alternative Technologies: Emerging blood sampling technologies, such as continuous glucose monitoring (CGM) systems that reduce the need for finger pricking, may present competition to safety lancets.
Limited Reimbursement Policies: In some regions, the lack of favorable reimbursement policies for diagnostic devices like safety lancets can act as a barrier to widespread adoption.
LP Information, Inc. (LPI) ' newest research report, the ?Safety Lancets Industry Forecast? looks at past sales and reviews total world Safety Lancets sales in 2025, providing a comprehensive analysis by region and market sector of projected Safety Lancets sales for 2026 through 2032. With Safety Lancets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Safety Lancets industry.
This Insight Report provides a comprehensive analysis of the global Safety Lancets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Safety Lancets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Safety Lancets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Safety Lancets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Safety Lancets.
This report presents a comprehensive overview, market shares, and growth opportunities of Safety Lancets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Safety Lancets with Needle
- Safety Lancets with Blade
- Diabetes Care
- Hospital Use
- Home Testing
- Fixed Depth
- Adjustable Depth
- Hospital & Clinics
- Home
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- BD
- Ascensia
- Lifescan
- B. Braun
- Terumo
- Nipro
- Cardinal Health
- ARKRAY
- ICU Medical
- Owen Mumford
- HemoCue
- Greiner Bio One
- HTL-STREFA
- Sarstedt
- UltiMed
- Tianjin Huahong
- Guangzhou iCare Medical
- Shandong Lianfa
- SteriLance Medical
- What is the 10-year outlook for the global Safety Lancets market?
- What factors are driving Safety Lancets market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doSafety Lancets market opportunities vary by end market size?
- How does Safety Lancets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Safety Lancets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Safety Lancets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Safety Lancets by Country/Region, 2021, 2025 & 2032
2.2 Safety Lancets Segment by Type
2.2.1 Safety Lancets with Needle
2.2.2 Safety Lancets with Blade
2.2.3 Safety Lancets Sales by Type
2.2.3.1 Global Safety Lancets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Safety Lancets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Safety Lancets Sale Price by Type (2021-2026)
2.3 Safety Lancets Segment by End Users
2.3.1 Diabetes Care
2.3.2 Hospital Use
2.3.3 Home Testing
2.3.4 Safety Lancets Sales by End Users
2.3.4.1 Global Safety Lancets Sales Market Share by End Users (2021-2026)
2.3.4.2 Global Safety Lancets Revenue and Market Share by End Users (2021-2026)
2.3.4.3 Global Safety Lancets Sale Price by End Users (2021-2026)
2.4 Safety Lancets Segment by Depth Control
2.4.1 Fixed Depth
2.4.2 Adjustable Depth
2.4.3 Safety Lancets Sales by Depth Control
2.4.3.1 Global Safety Lancets Sales Market Share by Depth Control (2021-2026)
2.4.3.2 Global Safety Lancets Revenue and Market Share by Depth Control (2021-2026)
2.4.3.3 Global Safety Lancets Sale Price by Depth Control (2021-2026)
2.5 Safety Lancets Segment by Application
2.5.1 Hospital & Clinics
2.5.2 Home
2.5.3 Other
2.5.4 Safety Lancets Sales by Application
2.5.4.1 Global Safety Lancets Sale Market Share by Application (2021-2026)
2.5.4.2 Global Safety Lancets Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Safety Lancets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Safety Lancets Breakdown Data by Company
3.1.1 Global Safety Lancets Annual Sales by Company (2021-2026)
3.1.2 Global Safety Lancets Sales Market Share by Company (2021-2026)
3.2 Global Safety Lancets Annual Revenue by Company (2021-2026)
3.2.1 Global Safety Lancets Revenue by Company (2021-2026)
3.2.2 Global Safety Lancets Revenue Market Share by Company (2021-2026)
3.3 Global Safety Lancets Sale Price by Company
3.4 Key Manufacturers Safety Lancets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Safety Lancets Product Location Distribution
3.4.2 Players Safety Lancets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SAFETY LANCETS BY GEOGRAPHIC REGION
4.1 World Historic Safety Lancets Market Size by Geographic Region (2021-2026)
4.1.1 Global Safety Lancets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Safety Lancets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Safety Lancets Market Size by Country/Region (2021-2026)
4.2.1 Global Safety Lancets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Safety Lancets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Safety Lancets Sales Growth
4.4 APAC Safety Lancets Sales Growth
4.5 Europe Safety Lancets Sales Growth
4.6 Middle East & Africa Safety Lancets Sales Growth
5 AMERICAS
5.1 Americas Safety Lancets Sales by Country
5.1.1 Americas Safety Lancets Sales by Country (2021-2026)
5.1.2 Americas Safety Lancets Revenue by Country (2021-2026)
5.2 Americas Safety Lancets Sales by Type (2021-2026)
5.3 Americas Safety Lancets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Safety Lancets Sales by Region
6.1.1 APAC Safety Lancets Sales by Region (2021-2026)
6.1.2 APAC Safety Lancets Revenue by Region (2021-2026)
6.2 APAC Safety Lancets Sales by Type (2021-2026)
6.3 APAC Safety Lancets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Safety Lancets by Country
7.1.1 Europe Safety Lancets Sales by Country (2021-2026)
7.1.2 Europe Safety Lancets Revenue by Country (2021-2026)
7.2 Europe Safety Lancets Sales by Type (2021-2026)
7.3 Europe Safety Lancets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Safety Lancets by Country
8.1.1 Middle East & Africa Safety Lancets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Safety Lancets Revenue by Country (2021-2026)
8.2 Middle East & Africa Safety Lancets Sales by Type (2021-2026)
8.3 Middle East & Africa Safety Lancets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Safety Lancets
10.3 Manufacturing Process Analysis of Safety Lancets
10.4 Industry Chain Structure of Safety Lancets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Safety Lancets Distributors
11.3 Safety Lancets Customer
12 WORLD FORECAST REVIEW FOR SAFETY LANCETS BY GEOGRAPHIC REGION
12.1 Global Safety Lancets Market Size Forecast by Region
12.1.1 Global Safety Lancets Forecast by Region (2027-2032)
12.1.2 Global Safety Lancets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Safety Lancets Forecast by Type (2027-2032)
12.7 Global Safety Lancets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Safety Lancets Product Portfolios and Specifications
13.1.3 Roche Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Safety Lancets Product Portfolios and Specifications
13.2.3 BD Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Ascensia
13.3.1 Ascensia Company Information
13.3.2 Ascensia Safety Lancets Product Portfolios and Specifications
13.3.3 Ascensia Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Ascensia Main Business Overview
13.3.5 Ascensia Latest Developments
13.4 Lifescan
13.4.1 Lifescan Company Information
13.4.2 Lifescan Safety Lancets Product Portfolios and Specifications
13.4.3 Lifescan Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lifescan Main Business Overview
13.4.5 Lifescan Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Safety Lancets Product Portfolios and Specifications
13.5.3 B. Braun Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Safety Lancets Product Portfolios and Specifications
13.6.3 Terumo Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
13.7 Nipro
13.7.1 Nipro Company Information
13.7.2 Nipro Safety Lancets Product Portfolios and Specifications
13.7.3 Nipro Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Nipro Main Business Overview
13.7.5 Nipro Latest Developments
13.8 Cardinal Health
13.8.1 Cardinal Health Company Information
13.8.2 Cardinal Health Safety Lancets Product Portfolios and Specifications
13.8.3 Cardinal Health Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Cardinal Health Main Business Overview
13.8.5 Cardinal Health Latest Developments
13.9 ARKRAY
13.9.1 ARKRAY Company Information
13.9.2 ARKRAY Safety Lancets Product Portfolios and Specifications
13.9.3 ARKRAY Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 ARKRAY Main Business Overview
13.9.5 ARKRAY Latest Developments
13.10 ICU Medical
13.10.1 ICU Medical Company Information
13.10.2 ICU Medical Safety Lancets Product Portfolios and Specifications
13.10.3 ICU Medical Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 ICU Medical Main Business Overview
13.10.5 ICU Medical Latest Developments
13.11 Owen Mumford
13.11.1 Owen Mumford Company Information
13.11.2 Owen Mumford Safety Lancets Product Portfolios and Specifications
13.11.3 Owen Mumford Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Owen Mumford Main Business Overview
13.11.5 Owen Mumford Latest Developments
13.12 HemoCue
13.12.1 HemoCue Company Information
13.12.2 HemoCue Safety Lancets Product Portfolios and Specifications
13.12.3 HemoCue Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 HemoCue Main Business Overview
13.12.5 HemoCue Latest Developments
13.13 Greiner Bio One
13.13.1 Greiner Bio One Company Information
13.13.2 Greiner Bio One Safety Lancets Product Portfolios and Specifications
13.13.3 Greiner Bio One Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Greiner Bio One Main Business Overview
13.13.5 Greiner Bio One Latest Developments
13.14 HTL-STREFA
13.14.1 HTL-STREFA Company Information
13.14.2 HTL-STREFA Safety Lancets Product Portfolios and Specifications
13.14.3 HTL-STREFA Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 HTL-STREFA Main Business Overview
13.14.5 HTL-STREFA Latest Developments
13.15 Sarstedt
13.15.1 Sarstedt Company Information
13.15.2 Sarstedt Safety Lancets Product Portfolios and Specifications
13.15.3 Sarstedt Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sarstedt Main Business Overview
13.15.5 Sarstedt Latest Developments
13.16 UltiMed
13.16.1 UltiMed Company Information
13.16.2 UltiMed Safety Lancets Product Portfolios and Specifications
13.16.3 UltiMed Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 UltiMed Main Business Overview
13.16.5 UltiMed Latest Developments
13.17 Tianjin Huahong
13.17.1 Tianjin Huahong Company Information
13.17.2 Tianjin Huahong Safety Lancets Product Portfolios and Specifications
13.17.3 Tianjin Huahong Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Tianjin Huahong Main Business Overview
13.17.5 Tianjin Huahong Latest Developments
13.18 Guangzhou iCare Medical
13.18.1 Guangzhou iCare Medical Company Information
13.18.2 Guangzhou iCare Medical Safety Lancets Product Portfolios and Specifications
13.18.3 Guangzhou iCare Medical Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Guangzhou iCare Medical Main Business Overview
13.18.5 Guangzhou iCare Medical Latest Developments
13.19 Shandong Lianfa
13.19.1 Shandong Lianfa Company Information
13.19.2 Shandong Lianfa Safety Lancets Product Portfolios and Specifications
13.19.3 Shandong Lianfa Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Shandong Lianfa Main Business Overview
13.19.5 Shandong Lianfa Latest Developments
13.20 SteriLance Medical
13.20.1 SteriLance Medical Company Information
13.20.2 SteriLance Medical Safety Lancets Product Portfolios and Specifications
13.20.3 SteriLance Medical Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 SteriLance Medical Main Business Overview
13.20.5 SteriLance Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Safety Lancets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Safety Lancets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Safety Lancets by Country/Region, 2021, 2025 & 2032
2.2 Safety Lancets Segment by Type
2.2.1 Safety Lancets with Needle
2.2.2 Safety Lancets with Blade
2.2.3 Safety Lancets Sales by Type
2.2.3.1 Global Safety Lancets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Safety Lancets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Safety Lancets Sale Price by Type (2021-2026)
2.3 Safety Lancets Segment by End Users
2.3.1 Diabetes Care
2.3.2 Hospital Use
2.3.3 Home Testing
2.3.4 Safety Lancets Sales by End Users
2.3.4.1 Global Safety Lancets Sales Market Share by End Users (2021-2026)
2.3.4.2 Global Safety Lancets Revenue and Market Share by End Users (2021-2026)
2.3.4.3 Global Safety Lancets Sale Price by End Users (2021-2026)
2.4 Safety Lancets Segment by Depth Control
2.4.1 Fixed Depth
2.4.2 Adjustable Depth
2.4.3 Safety Lancets Sales by Depth Control
2.4.3.1 Global Safety Lancets Sales Market Share by Depth Control (2021-2026)
2.4.3.2 Global Safety Lancets Revenue and Market Share by Depth Control (2021-2026)
2.4.3.3 Global Safety Lancets Sale Price by Depth Control (2021-2026)
2.5 Safety Lancets Segment by Application
2.5.1 Hospital & Clinics
2.5.2 Home
2.5.3 Other
2.5.4 Safety Lancets Sales by Application
2.5.4.1 Global Safety Lancets Sale Market Share by Application (2021-2026)
2.5.4.2 Global Safety Lancets Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Safety Lancets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Safety Lancets Breakdown Data by Company
3.1.1 Global Safety Lancets Annual Sales by Company (2021-2026)
3.1.2 Global Safety Lancets Sales Market Share by Company (2021-2026)
3.2 Global Safety Lancets Annual Revenue by Company (2021-2026)
3.2.1 Global Safety Lancets Revenue by Company (2021-2026)
3.2.2 Global Safety Lancets Revenue Market Share by Company (2021-2026)
3.3 Global Safety Lancets Sale Price by Company
3.4 Key Manufacturers Safety Lancets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Safety Lancets Product Location Distribution
3.4.2 Players Safety Lancets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SAFETY LANCETS BY GEOGRAPHIC REGION
4.1 World Historic Safety Lancets Market Size by Geographic Region (2021-2026)
4.1.1 Global Safety Lancets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Safety Lancets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Safety Lancets Market Size by Country/Region (2021-2026)
4.2.1 Global Safety Lancets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Safety Lancets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Safety Lancets Sales Growth
4.4 APAC Safety Lancets Sales Growth
4.5 Europe Safety Lancets Sales Growth
4.6 Middle East & Africa Safety Lancets Sales Growth
5 AMERICAS
5.1 Americas Safety Lancets Sales by Country
5.1.1 Americas Safety Lancets Sales by Country (2021-2026)
5.1.2 Americas Safety Lancets Revenue by Country (2021-2026)
5.2 Americas Safety Lancets Sales by Type (2021-2026)
5.3 Americas Safety Lancets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Safety Lancets Sales by Region
6.1.1 APAC Safety Lancets Sales by Region (2021-2026)
6.1.2 APAC Safety Lancets Revenue by Region (2021-2026)
6.2 APAC Safety Lancets Sales by Type (2021-2026)
6.3 APAC Safety Lancets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Safety Lancets by Country
7.1.1 Europe Safety Lancets Sales by Country (2021-2026)
7.1.2 Europe Safety Lancets Revenue by Country (2021-2026)
7.2 Europe Safety Lancets Sales by Type (2021-2026)
7.3 Europe Safety Lancets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Safety Lancets by Country
8.1.1 Middle East & Africa Safety Lancets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Safety Lancets Revenue by Country (2021-2026)
8.2 Middle East & Africa Safety Lancets Sales by Type (2021-2026)
8.3 Middle East & Africa Safety Lancets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Safety Lancets
10.3 Manufacturing Process Analysis of Safety Lancets
10.4 Industry Chain Structure of Safety Lancets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Safety Lancets Distributors
11.3 Safety Lancets Customer
12 WORLD FORECAST REVIEW FOR SAFETY LANCETS BY GEOGRAPHIC REGION
12.1 Global Safety Lancets Market Size Forecast by Region
12.1.1 Global Safety Lancets Forecast by Region (2027-2032)
12.1.2 Global Safety Lancets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Safety Lancets Forecast by Type (2027-2032)
12.7 Global Safety Lancets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Safety Lancets Product Portfolios and Specifications
13.1.3 Roche Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Safety Lancets Product Portfolios and Specifications
13.2.3 BD Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Ascensia
13.3.1 Ascensia Company Information
13.3.2 Ascensia Safety Lancets Product Portfolios and Specifications
13.3.3 Ascensia Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Ascensia Main Business Overview
13.3.5 Ascensia Latest Developments
13.4 Lifescan
13.4.1 Lifescan Company Information
13.4.2 Lifescan Safety Lancets Product Portfolios and Specifications
13.4.3 Lifescan Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lifescan Main Business Overview
13.4.5 Lifescan Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Safety Lancets Product Portfolios and Specifications
13.5.3 B. Braun Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Safety Lancets Product Portfolios and Specifications
13.6.3 Terumo Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
13.7 Nipro
13.7.1 Nipro Company Information
13.7.2 Nipro Safety Lancets Product Portfolios and Specifications
13.7.3 Nipro Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Nipro Main Business Overview
13.7.5 Nipro Latest Developments
13.8 Cardinal Health
13.8.1 Cardinal Health Company Information
13.8.2 Cardinal Health Safety Lancets Product Portfolios and Specifications
13.8.3 Cardinal Health Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Cardinal Health Main Business Overview
13.8.5 Cardinal Health Latest Developments
13.9 ARKRAY
13.9.1 ARKRAY Company Information
13.9.2 ARKRAY Safety Lancets Product Portfolios and Specifications
13.9.3 ARKRAY Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 ARKRAY Main Business Overview
13.9.5 ARKRAY Latest Developments
13.10 ICU Medical
13.10.1 ICU Medical Company Information
13.10.2 ICU Medical Safety Lancets Product Portfolios and Specifications
13.10.3 ICU Medical Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 ICU Medical Main Business Overview
13.10.5 ICU Medical Latest Developments
13.11 Owen Mumford
13.11.1 Owen Mumford Company Information
13.11.2 Owen Mumford Safety Lancets Product Portfolios and Specifications
13.11.3 Owen Mumford Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Owen Mumford Main Business Overview
13.11.5 Owen Mumford Latest Developments
13.12 HemoCue
13.12.1 HemoCue Company Information
13.12.2 HemoCue Safety Lancets Product Portfolios and Specifications
13.12.3 HemoCue Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 HemoCue Main Business Overview
13.12.5 HemoCue Latest Developments
13.13 Greiner Bio One
13.13.1 Greiner Bio One Company Information
13.13.2 Greiner Bio One Safety Lancets Product Portfolios and Specifications
13.13.3 Greiner Bio One Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Greiner Bio One Main Business Overview
13.13.5 Greiner Bio One Latest Developments
13.14 HTL-STREFA
13.14.1 HTL-STREFA Company Information
13.14.2 HTL-STREFA Safety Lancets Product Portfolios and Specifications
13.14.3 HTL-STREFA Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 HTL-STREFA Main Business Overview
13.14.5 HTL-STREFA Latest Developments
13.15 Sarstedt
13.15.1 Sarstedt Company Information
13.15.2 Sarstedt Safety Lancets Product Portfolios and Specifications
13.15.3 Sarstedt Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sarstedt Main Business Overview
13.15.5 Sarstedt Latest Developments
13.16 UltiMed
13.16.1 UltiMed Company Information
13.16.2 UltiMed Safety Lancets Product Portfolios and Specifications
13.16.3 UltiMed Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 UltiMed Main Business Overview
13.16.5 UltiMed Latest Developments
13.17 Tianjin Huahong
13.17.1 Tianjin Huahong Company Information
13.17.2 Tianjin Huahong Safety Lancets Product Portfolios and Specifications
13.17.3 Tianjin Huahong Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Tianjin Huahong Main Business Overview
13.17.5 Tianjin Huahong Latest Developments
13.18 Guangzhou iCare Medical
13.18.1 Guangzhou iCare Medical Company Information
13.18.2 Guangzhou iCare Medical Safety Lancets Product Portfolios and Specifications
13.18.3 Guangzhou iCare Medical Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Guangzhou iCare Medical Main Business Overview
13.18.5 Guangzhou iCare Medical Latest Developments
13.19 Shandong Lianfa
13.19.1 Shandong Lianfa Company Information
13.19.2 Shandong Lianfa Safety Lancets Product Portfolios and Specifications
13.19.3 Shandong Lianfa Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Shandong Lianfa Main Business Overview
13.19.5 Shandong Lianfa Latest Developments
13.20 SteriLance Medical
13.20.1 SteriLance Medical Company Information
13.20.2 SteriLance Medical Safety Lancets Product Portfolios and Specifications
13.20.3 SteriLance Medical Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 SteriLance Medical Main Business Overview
13.20.5 SteriLance Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Safety Lancets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Safety Lancets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Safety Lancets with Needle
Table 4. Major Players of Safety Lancets with Blade
Table 5. Global Safety Lancets Sales by Type (2021-2026) & (M Units)
Table 6. Global Safety Lancets Sales Market Share by Type (2021-2026)
Table 7. Global Safety Lancets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Safety Lancets Revenue Market Share by Type (2021-2026)
Table 9. Global Safety Lancets Sale Price by Type (2021-2026) & (US$/K Units)
Table 10. Major Players of Diabetes Care
Table 11. Major Players of Hospital Use
Table 12. Major Players of Home Testing
Table 13. Global Safety Lancets Sales by End Users (2021-2026) & (M Units)
Table 14. Global Safety Lancets Sales Market Share by End Users (2021-2026)
Table 15. Global Safety Lancets Revenue by End Users (2021-2026) & ($ million)
Table 16. Global Safety Lancets Revenue Market Share by End Users (2021-2026)
Table 17. Global Safety Lancets Sale Price by End Users (2021-2026) & (US$/K Units)
Table 18. Major Players of Fixed Depth
Table 19. Major Players of Adjustable Depth
Table 20. Global Safety Lancets Sales by Depth Control (2021-2026) & (M Units)
Table 21. Global Safety Lancets Sales Market Share by Depth Control (2021-2026)
Table 22. Global Safety Lancets Revenue by Depth Control (2021-2026) & ($ million)
Table 23. Global Safety Lancets Revenue Market Share by Depth Control (2021-2026)
Table 24. Global Safety Lancets Sale Price by Depth Control (2021-2026) & (US$/K Units)
Table 25. Global Safety Lancets Sale by Application (2021-2026) & (M Units)
Table 26. Global Safety Lancets Sale Market Share by Application (2021-2026)
Table 27. Global Safety Lancets Revenue by Application (2021-2026) & ($ million)
Table 28. Global Safety Lancets Revenue Market Share by Application (2021-2026)
Table 29. Global Safety Lancets Sale Price by Application (2021-2026) & (US$/K Units)
Table 30. Global Safety Lancets Sales by Company (2021-2026) & (M Units)
Table 31. Global Safety Lancets Sales Market Share by Company (2021-2026)
Table 32. Global Safety Lancets Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Safety Lancets Revenue Market Share by Company (2021-2026)
Table 34. Global Safety Lancets Sale Price by Company (2021-2026) & (US$/K Units)
Table 35. Key Manufacturers Safety Lancets Producing Area Distribution and Sales Area
Table 36. Players Safety Lancets Products Offered
Table 37. Safety Lancets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Safety Lancets Sales by Geographic Region (2021-2026) & (M Units)
Table 41. Global Safety Lancets Sales Market Share Geographic Region (2021-2026)
Table 42. Global Safety Lancets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Safety Lancets Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Safety Lancets Sales by Country/Region (2021-2026) & (M Units)
Table 45. Global Safety Lancets Sales Market Share by Country/Region (2021-2026)
Table 46. Global Safety Lancets Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Safety Lancets Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Safety Lancets Sales by Country (2021-2026) & (M Units)
Table 49. Americas Safety Lancets Sales Market Share by Country (2021-2026)
Table 50. Americas Safety Lancets Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Safety Lancets Sales by Type (2021-2026) & (M Units)
Table 52. Americas Safety Lancets Sales by Application (2021-2026) & (M Units)
Table 53. APAC Safety Lancets Sales by Region (2021-2026) & (M Units)
Table 54. APAC Safety Lancets Sales Market Share by Region (2021-2026)
Table 55. APAC Safety Lancets Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Safety Lancets Sales by Type (2021-2026) & (M Units)
Table 57. APAC Safety Lancets Sales by Application (2021-2026) & (M Units)
Table 58. Europe Safety Lancets Sales by Country (2021-2026) & (M Units)
Table 59. Europe Safety Lancets Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Safety Lancets Sales by Type (2021-2026) & (M Units)
Table 61. Europe Safety Lancets Sales by Application (2021-2026) & (M Units)
Table 62. Middle East & Africa Safety Lancets Sales by Country (2021-2026) & (M Units)
Table 63. Middle East & Africa Safety Lancets Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Safety Lancets Sales by Type (2021-2026) & (M Units)
Table 65. Middle East & Africa Safety Lancets Sales by Application (2021-2026) & (M Units)
Table 66. Key Market Drivers & Growth Opportunities of Safety Lancets
Table 67. Key Market Challenges & Risks of Safety Lancets
Table 68. Key Industry Trends of Safety Lancets
Table 69. Safety Lancets Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Safety Lancets Distributors List
Table 72. Safety Lancets Customer List
Table 73. Global Safety Lancets Sales Forecast by Region (2027-2032) & (M Units)
Table 74. Global Safety Lancets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Safety Lancets Sales Forecast by Country (2027-2032) & (M Units)
Table 76. Americas Safety Lancets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Safety Lancets Sales Forecast by Region (2027-2032) & (M Units)
Table 78. APAC Safety Lancets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Safety Lancets Sales Forecast by Country (2027-2032) & (M Units)
Table 80. Europe Safety Lancets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Safety Lancets Sales Forecast by Country (2027-2032) & (M Units)
Table 82. Middle East & Africa Safety Lancets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Safety Lancets Sales Forecast by Type (2027-2032) & (M Units)
Table 84. Global Safety Lancets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Safety Lancets Sales Forecast by Application (2027-2032) & (M Units)
Table 86. Global Safety Lancets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Roche Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Safety Lancets Product Portfolios and Specifications
Table 89. Roche Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. BD Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 93. BD Safety Lancets Product Portfolios and Specifications
Table 94. BD Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 95. BD Main Business
Table 96. BD Latest Developments
Table 97. Ascensia Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 98. Ascensia Safety Lancets Product Portfolios and Specifications
Table 99. Ascensia Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 100. Ascensia Main Business
Table 101. Ascensia Latest Developments
Table 102. Lifescan Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 103. Lifescan Safety Lancets Product Portfolios and Specifications
Table 104. Lifescan Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 105. Lifescan Main Business
Table 106. Lifescan Latest Developments
Table 107. B. Braun Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 108. B. Braun Safety Lancets Product Portfolios and Specifications
Table 109. B. Braun Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 110. B. Braun Main Business
Table 111. B. Braun Latest Developments
Table 112. Terumo Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 113. Terumo Safety Lancets Product Portfolios and Specifications
Table 114. Terumo Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 115. Terumo Main Business
Table 116. Terumo Latest Developments
Table 117. Nipro Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 118. Nipro Safety Lancets Product Portfolios and Specifications
Table 119. Nipro Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 120. Nipro Main Business
Table 121. Nipro Latest Developments
Table 122. Cardinal Health Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 123. Cardinal Health Safety Lancets Product Portfolios and Specifications
Table 124. Cardinal Health Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 125. Cardinal Health Main Business
Table 126. Cardinal Health Latest Developments
Table 127. ARKRAY Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 128. ARKRAY Safety Lancets Product Portfolios and Specifications
Table 129. ARKRAY Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 130. ARKRAY Main Business
Table 131. ARKRAY Latest Developments
Table 132. ICU Medical Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 133. ICU Medical Safety Lancets Product Portfolios and Specifications
Table 134. ICU Medical Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 135. ICU Medical Main Business
Table 136. ICU Medical Latest Developments
Table 137. Owen Mumford Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 138. Owen Mumford Safety Lancets Product Portfolios and Specifications
Table 139. Owen Mumford Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 140. Owen Mumford Main Business
Table 141. Owen Mumford Latest Developments
Table 142. HemoCue Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 143. HemoCue Safety Lancets Product Portfolios and Specifications
Table 144. HemoCue Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 145. HemoCue Main Business
Table 146. HemoCue Latest Developments
Table 147. Greiner Bio One Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 148. Greiner Bio One Safety Lancets Product Portfolios and Specifications
Table 149. Greiner Bio One Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 150. Greiner Bio One Main Business
Table 151. Greiner Bio One Latest Developments
Table 152. HTL-STREFA Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 153. HTL-STREFA Safety Lancets Product Portfolios and Specifications
Table 154. HTL-STREFA Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 155. HTL-STREFA Main Business
Table 156. HTL-STREFA Latest Developments
Table 157. Sarstedt Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 158. Sarstedt Safety Lancets Product Portfolios and Specifications
Table 159. Sarstedt Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 160. Sarstedt Main Business
Table 161. Sarstedt Latest Developments
Table 162. UltiMed Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 163. UltiMed Safety Lancets Product Portfolios and Specifications
Table 164. UltiMed Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 165. UltiMed Main Business
Table 166. UltiMed Latest Developments
Table 167. Tianjin Huahong Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 168. Tianjin Huahong Safety Lancets Product Portfolios and Specifications
Table 169. Tianjin Huahong Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 170. Tianjin Huahong Main Business
Table 171. Tianjin Huahong Latest Developments
Table 172. Guangzhou iCare Medical Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 173. Guangzhou iCare Medical Safety Lancets Product Portfolios and Specifications
Table 174. Guangzhou iCare Medical Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 175. Guangzhou iCare Medical Main Business
Table 176. Guangzhou iCare Medical Latest Developments
Table 177. Shandong Lianfa Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 178. Shandong Lianfa Safety Lancets Product Portfolios and Specifications
Table 179. Shandong Lianfa Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 180. Shandong Lianfa Main Business
Table 181. Shandong Lianfa Latest Developments
Table 182. SteriLance Medical Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 183. SteriLance Medical Safety Lancets Product Portfolios and Specifications
Table 184. SteriLance Medical Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 185. SteriLance Medical Main Business
Table 186. SteriLance Medical Latest Developments
Table 1. Safety Lancets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Safety Lancets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Safety Lancets with Needle
Table 4. Major Players of Safety Lancets with Blade
Table 5. Global Safety Lancets Sales by Type (2021-2026) & (M Units)
Table 6. Global Safety Lancets Sales Market Share by Type (2021-2026)
Table 7. Global Safety Lancets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Safety Lancets Revenue Market Share by Type (2021-2026)
Table 9. Global Safety Lancets Sale Price by Type (2021-2026) & (US$/K Units)
Table 10. Major Players of Diabetes Care
Table 11. Major Players of Hospital Use
Table 12. Major Players of Home Testing
Table 13. Global Safety Lancets Sales by End Users (2021-2026) & (M Units)
Table 14. Global Safety Lancets Sales Market Share by End Users (2021-2026)
Table 15. Global Safety Lancets Revenue by End Users (2021-2026) & ($ million)
Table 16. Global Safety Lancets Revenue Market Share by End Users (2021-2026)
Table 17. Global Safety Lancets Sale Price by End Users (2021-2026) & (US$/K Units)
Table 18. Major Players of Fixed Depth
Table 19. Major Players of Adjustable Depth
Table 20. Global Safety Lancets Sales by Depth Control (2021-2026) & (M Units)
Table 21. Global Safety Lancets Sales Market Share by Depth Control (2021-2026)
Table 22. Global Safety Lancets Revenue by Depth Control (2021-2026) & ($ million)
Table 23. Global Safety Lancets Revenue Market Share by Depth Control (2021-2026)
Table 24. Global Safety Lancets Sale Price by Depth Control (2021-2026) & (US$/K Units)
Table 25. Global Safety Lancets Sale by Application (2021-2026) & (M Units)
Table 26. Global Safety Lancets Sale Market Share by Application (2021-2026)
Table 27. Global Safety Lancets Revenue by Application (2021-2026) & ($ million)
Table 28. Global Safety Lancets Revenue Market Share by Application (2021-2026)
Table 29. Global Safety Lancets Sale Price by Application (2021-2026) & (US$/K Units)
Table 30. Global Safety Lancets Sales by Company (2021-2026) & (M Units)
Table 31. Global Safety Lancets Sales Market Share by Company (2021-2026)
Table 32. Global Safety Lancets Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Safety Lancets Revenue Market Share by Company (2021-2026)
Table 34. Global Safety Lancets Sale Price by Company (2021-2026) & (US$/K Units)
Table 35. Key Manufacturers Safety Lancets Producing Area Distribution and Sales Area
Table 36. Players Safety Lancets Products Offered
Table 37. Safety Lancets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Safety Lancets Sales by Geographic Region (2021-2026) & (M Units)
Table 41. Global Safety Lancets Sales Market Share Geographic Region (2021-2026)
Table 42. Global Safety Lancets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Safety Lancets Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Safety Lancets Sales by Country/Region (2021-2026) & (M Units)
Table 45. Global Safety Lancets Sales Market Share by Country/Region (2021-2026)
Table 46. Global Safety Lancets Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Safety Lancets Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Safety Lancets Sales by Country (2021-2026) & (M Units)
Table 49. Americas Safety Lancets Sales Market Share by Country (2021-2026)
Table 50. Americas Safety Lancets Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Safety Lancets Sales by Type (2021-2026) & (M Units)
Table 52. Americas Safety Lancets Sales by Application (2021-2026) & (M Units)
Table 53. APAC Safety Lancets Sales by Region (2021-2026) & (M Units)
Table 54. APAC Safety Lancets Sales Market Share by Region (2021-2026)
Table 55. APAC Safety Lancets Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Safety Lancets Sales by Type (2021-2026) & (M Units)
Table 57. APAC Safety Lancets Sales by Application (2021-2026) & (M Units)
Table 58. Europe Safety Lancets Sales by Country (2021-2026) & (M Units)
Table 59. Europe Safety Lancets Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Safety Lancets Sales by Type (2021-2026) & (M Units)
Table 61. Europe Safety Lancets Sales by Application (2021-2026) & (M Units)
Table 62. Middle East & Africa Safety Lancets Sales by Country (2021-2026) & (M Units)
Table 63. Middle East & Africa Safety Lancets Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Safety Lancets Sales by Type (2021-2026) & (M Units)
Table 65. Middle East & Africa Safety Lancets Sales by Application (2021-2026) & (M Units)
Table 66. Key Market Drivers & Growth Opportunities of Safety Lancets
Table 67. Key Market Challenges & Risks of Safety Lancets
Table 68. Key Industry Trends of Safety Lancets
Table 69. Safety Lancets Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Safety Lancets Distributors List
Table 72. Safety Lancets Customer List
Table 73. Global Safety Lancets Sales Forecast by Region (2027-2032) & (M Units)
Table 74. Global Safety Lancets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Safety Lancets Sales Forecast by Country (2027-2032) & (M Units)
Table 76. Americas Safety Lancets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Safety Lancets Sales Forecast by Region (2027-2032) & (M Units)
Table 78. APAC Safety Lancets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Safety Lancets Sales Forecast by Country (2027-2032) & (M Units)
Table 80. Europe Safety Lancets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Safety Lancets Sales Forecast by Country (2027-2032) & (M Units)
Table 82. Middle East & Africa Safety Lancets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Safety Lancets Sales Forecast by Type (2027-2032) & (M Units)
Table 84. Global Safety Lancets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Safety Lancets Sales Forecast by Application (2027-2032) & (M Units)
Table 86. Global Safety Lancets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Roche Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Safety Lancets Product Portfolios and Specifications
Table 89. Roche Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. BD Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 93. BD Safety Lancets Product Portfolios and Specifications
Table 94. BD Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 95. BD Main Business
Table 96. BD Latest Developments
Table 97. Ascensia Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 98. Ascensia Safety Lancets Product Portfolios and Specifications
Table 99. Ascensia Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 100. Ascensia Main Business
Table 101. Ascensia Latest Developments
Table 102. Lifescan Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 103. Lifescan Safety Lancets Product Portfolios and Specifications
Table 104. Lifescan Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 105. Lifescan Main Business
Table 106. Lifescan Latest Developments
Table 107. B. Braun Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 108. B. Braun Safety Lancets Product Portfolios and Specifications
Table 109. B. Braun Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 110. B. Braun Main Business
Table 111. B. Braun Latest Developments
Table 112. Terumo Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 113. Terumo Safety Lancets Product Portfolios and Specifications
Table 114. Terumo Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 115. Terumo Main Business
Table 116. Terumo Latest Developments
Table 117. Nipro Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 118. Nipro Safety Lancets Product Portfolios and Specifications
Table 119. Nipro Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 120. Nipro Main Business
Table 121. Nipro Latest Developments
Table 122. Cardinal Health Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 123. Cardinal Health Safety Lancets Product Portfolios and Specifications
Table 124. Cardinal Health Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 125. Cardinal Health Main Business
Table 126. Cardinal Health Latest Developments
Table 127. ARKRAY Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 128. ARKRAY Safety Lancets Product Portfolios and Specifications
Table 129. ARKRAY Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 130. ARKRAY Main Business
Table 131. ARKRAY Latest Developments
Table 132. ICU Medical Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 133. ICU Medical Safety Lancets Product Portfolios and Specifications
Table 134. ICU Medical Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 135. ICU Medical Main Business
Table 136. ICU Medical Latest Developments
Table 137. Owen Mumford Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 138. Owen Mumford Safety Lancets Product Portfolios and Specifications
Table 139. Owen Mumford Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 140. Owen Mumford Main Business
Table 141. Owen Mumford Latest Developments
Table 142. HemoCue Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 143. HemoCue Safety Lancets Product Portfolios and Specifications
Table 144. HemoCue Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 145. HemoCue Main Business
Table 146. HemoCue Latest Developments
Table 147. Greiner Bio One Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 148. Greiner Bio One Safety Lancets Product Portfolios and Specifications
Table 149. Greiner Bio One Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 150. Greiner Bio One Main Business
Table 151. Greiner Bio One Latest Developments
Table 152. HTL-STREFA Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 153. HTL-STREFA Safety Lancets Product Portfolios and Specifications
Table 154. HTL-STREFA Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 155. HTL-STREFA Main Business
Table 156. HTL-STREFA Latest Developments
Table 157. Sarstedt Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 158. Sarstedt Safety Lancets Product Portfolios and Specifications
Table 159. Sarstedt Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 160. Sarstedt Main Business
Table 161. Sarstedt Latest Developments
Table 162. UltiMed Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 163. UltiMed Safety Lancets Product Portfolios and Specifications
Table 164. UltiMed Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 165. UltiMed Main Business
Table 166. UltiMed Latest Developments
Table 167. Tianjin Huahong Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 168. Tianjin Huahong Safety Lancets Product Portfolios and Specifications
Table 169. Tianjin Huahong Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 170. Tianjin Huahong Main Business
Table 171. Tianjin Huahong Latest Developments
Table 172. Guangzhou iCare Medical Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 173. Guangzhou iCare Medical Safety Lancets Product Portfolios and Specifications
Table 174. Guangzhou iCare Medical Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 175. Guangzhou iCare Medical Main Business
Table 176. Guangzhou iCare Medical Latest Developments
Table 177. Shandong Lianfa Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 178. Shandong Lianfa Safety Lancets Product Portfolios and Specifications
Table 179. Shandong Lianfa Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 180. Shandong Lianfa Main Business
Table 181. Shandong Lianfa Latest Developments
Table 182. SteriLance Medical Basic Information, Safety Lancets Manufacturing Base, Sales Area and Its Competitors
Table 183. SteriLance Medical Safety Lancets Product Portfolios and Specifications
Table 184. SteriLance Medical Safety Lancets Sales (M Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 185. SteriLance Medical Main Business
Table 186. SteriLance Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Safety Lancets
Figure 2. Safety Lancets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Safety Lancets Sales Growth Rate 2021-2032 (M Units)
Figure 7. Global Safety Lancets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Safety Lancets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Safety Lancets Sales Market Share by Country/Region (2025)
Figure 10. Safety Lancets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Safety Lancets with Needle
Figure 12. Product Picture of Safety Lancets with Blade
Figure 13. Global Safety Lancets Sales Market Share by Type in 2026
Figure 14. Global Safety Lancets Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Diabetes Care
Figure 16. Product Picture of Hospital Use
Figure 17. Product Picture of Home Testing
Figure 18. Global Safety Lancets Sales Market Share by End Users in 2026
Figure 19. Global Safety Lancets Revenue Market Share by End Users (2021-2026)
Figure 20. Product Picture of Fixed Depth
Figure 21. Product Picture of Adjustable Depth
Figure 22. Global Safety Lancets Sales Market Share by Depth Control in 2026
Figure 23. Global Safety Lancets Revenue Market Share by Depth Control (2021-2026)
Figure 24. Safety Lancets Consumed in Hospital & Clinics
Figure 25. Global Safety Lancets Market: Hospital & Clinics (2021-2026) & (M Units)
Figure 26. Safety Lancets Consumed in Home
Figure 27. Global Safety Lancets Market: Home (2021-2026) & (M Units)
Figure 28. Safety Lancets Consumed in Other
Figure 29. Global Safety Lancets Market: Other (2021-2026) & (M Units)
Figure 30. Global Safety Lancets Sale Market Share by Application (2025)
Figure 31. Global Safety Lancets Revenue Market Share by Application in 2025
Figure 32. Safety Lancets Sales by Company in 2025 (M Units)
Figure 33. Global Safety Lancets Sales Market Share by Company in 2025
Figure 34. Safety Lancets Revenue by Company in 2025 ($ millions)
Figure 35. Global Safety Lancets Revenue Market Share by Company in 2025
Figure 36. Global Safety Lancets Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Safety Lancets Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Safety Lancets Sales 2021-2026 (M Units)
Figure 39. Americas Safety Lancets Revenue 2021-2026 ($ millions)
Figure 40. APAC Safety Lancets Sales 2021-2026 (M Units)
Figure 41. APAC Safety Lancets Revenue 2021-2026 ($ millions)
Figure 42. Europe Safety Lancets Sales 2021-2026 (M Units)
Figure 43. Europe Safety Lancets Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Safety Lancets Sales 2021-2026 (M Units)
Figure 45. Middle East & Africa Safety Lancets Revenue 2021-2026 ($ millions)
Figure 46. Americas Safety Lancets Sales Market Share by Country in 2025
Figure 47. Americas Safety Lancets Revenue Market Share by Country (2021-2026)
Figure 48. Americas Safety Lancets Sales Market Share by Type (2021-2026)
Figure 49. Americas Safety Lancets Sales Market Share by Application (2021-2026)
Figure 50. United States Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Safety Lancets Sales Market Share by Region in 2025
Figure 55. APAC Safety Lancets Revenue Market Share by Region (2021-2026)
Figure 56. APAC Safety Lancets Sales Market Share by Type (2021-2026)
Figure 57. APAC Safety Lancets Sales Market Share by Application (2021-2026)
Figure 58. China Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 62. India Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Safety Lancets Sales Market Share by Country in 2025
Figure 66. Europe Safety Lancets Revenue Market Share by Country (2021-2026)
Figure 67. Europe Safety Lancets Sales Market Share by Type (2021-2026)
Figure 68. Europe Safety Lancets Sales Market Share by Application (2021-2026)
Figure 69. Germany Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 70. France Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Safety Lancets Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Safety Lancets Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Safety Lancets Sales Market Share by Application (2021-2026)
Figure 77. Egypt Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Safety Lancets in 2026
Figure 83. Manufacturing Process Analysis of Safety Lancets
Figure 84. Industry Chain Structure of Safety Lancets
Figure 85. Channels of Distribution
Figure 86. Global Safety Lancets Sales Market Forecast by Region (2027-2032)
Figure 87. Global Safety Lancets Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Safety Lancets Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Safety Lancets Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Safety Lancets Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Safety Lancets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Safety Lancets
Figure 2. Safety Lancets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Safety Lancets Sales Growth Rate 2021-2032 (M Units)
Figure 7. Global Safety Lancets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Safety Lancets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Safety Lancets Sales Market Share by Country/Region (2025)
Figure 10. Safety Lancets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Safety Lancets with Needle
Figure 12. Product Picture of Safety Lancets with Blade
Figure 13. Global Safety Lancets Sales Market Share by Type in 2026
Figure 14. Global Safety Lancets Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Diabetes Care
Figure 16. Product Picture of Hospital Use
Figure 17. Product Picture of Home Testing
Figure 18. Global Safety Lancets Sales Market Share by End Users in 2026
Figure 19. Global Safety Lancets Revenue Market Share by End Users (2021-2026)
Figure 20. Product Picture of Fixed Depth
Figure 21. Product Picture of Adjustable Depth
Figure 22. Global Safety Lancets Sales Market Share by Depth Control in 2026
Figure 23. Global Safety Lancets Revenue Market Share by Depth Control (2021-2026)
Figure 24. Safety Lancets Consumed in Hospital & Clinics
Figure 25. Global Safety Lancets Market: Hospital & Clinics (2021-2026) & (M Units)
Figure 26. Safety Lancets Consumed in Home
Figure 27. Global Safety Lancets Market: Home (2021-2026) & (M Units)
Figure 28. Safety Lancets Consumed in Other
Figure 29. Global Safety Lancets Market: Other (2021-2026) & (M Units)
Figure 30. Global Safety Lancets Sale Market Share by Application (2025)
Figure 31. Global Safety Lancets Revenue Market Share by Application in 2025
Figure 32. Safety Lancets Sales by Company in 2025 (M Units)
Figure 33. Global Safety Lancets Sales Market Share by Company in 2025
Figure 34. Safety Lancets Revenue by Company in 2025 ($ millions)
Figure 35. Global Safety Lancets Revenue Market Share by Company in 2025
Figure 36. Global Safety Lancets Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Safety Lancets Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Safety Lancets Sales 2021-2026 (M Units)
Figure 39. Americas Safety Lancets Revenue 2021-2026 ($ millions)
Figure 40. APAC Safety Lancets Sales 2021-2026 (M Units)
Figure 41. APAC Safety Lancets Revenue 2021-2026 ($ millions)
Figure 42. Europe Safety Lancets Sales 2021-2026 (M Units)
Figure 43. Europe Safety Lancets Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Safety Lancets Sales 2021-2026 (M Units)
Figure 45. Middle East & Africa Safety Lancets Revenue 2021-2026 ($ millions)
Figure 46. Americas Safety Lancets Sales Market Share by Country in 2025
Figure 47. Americas Safety Lancets Revenue Market Share by Country (2021-2026)
Figure 48. Americas Safety Lancets Sales Market Share by Type (2021-2026)
Figure 49. Americas Safety Lancets Sales Market Share by Application (2021-2026)
Figure 50. United States Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Safety Lancets Sales Market Share by Region in 2025
Figure 55. APAC Safety Lancets Revenue Market Share by Region (2021-2026)
Figure 56. APAC Safety Lancets Sales Market Share by Type (2021-2026)
Figure 57. APAC Safety Lancets Sales Market Share by Application (2021-2026)
Figure 58. China Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 62. India Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Safety Lancets Sales Market Share by Country in 2025
Figure 66. Europe Safety Lancets Revenue Market Share by Country (2021-2026)
Figure 67. Europe Safety Lancets Sales Market Share by Type (2021-2026)
Figure 68. Europe Safety Lancets Sales Market Share by Application (2021-2026)
Figure 69. Germany Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 70. France Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Safety Lancets Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Safety Lancets Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Safety Lancets Sales Market Share by Application (2021-2026)
Figure 77. Egypt Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Safety Lancets Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Safety Lancets in 2026
Figure 83. Manufacturing Process Analysis of Safety Lancets
Figure 84. Industry Chain Structure of Safety Lancets
Figure 85. Channels of Distribution
Figure 86. Global Safety Lancets Sales Market Forecast by Region (2027-2032)
Figure 87. Global Safety Lancets Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Safety Lancets Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Safety Lancets Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Safety Lancets Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Safety Lancets Revenue Market Share Forecast by Application (2027-2032)
